Fig. 4

a T1 weighted sequence after gadoxetate disodium administration, arterial phase; b T1 weighted sequence, venous phase; c hepatobiliary phase—hypovascular, non-specific nodule. a The arrow is pointing to the hypointense hepatic nodule in the arterial phase after gadoxetate disodium administration. b The arrow is pointing to the hypointense hepatic nodule in the venous phase after gadoxetate disodium administration. c The arrow is pointing to the hypointense hepatic nodule in the hepatobiliary phase after gadoxetate disodium administration